Derazantinib
- Generic Name
- Derazantinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H29FN4O
- CAS Number
- 1234356-69-4
- Unique Ingredient Identifier
- N9B0H171MJ
- Background
Derazantinib is under investigation in clinical trial NCT03230318 (Derazantinib in Subjects With FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath